Company profile

DeuterOncology NV

Developing deuterated BEST in CLASS MET kinase Inhibitor

Industry
Biotechnology Research
Employees
2
Headquarters
Liège, Walloon Region
Founded
2020
LinkedIn followers
603
Office locations
1

DeuterOncology NV company summary

DeuterOncology NV is a company in the Biotechnology Research industry, headquartered in Liège, Walloon Region, founded in 2020. On LinkedIn the company has around 2 employees and 603 followers. Its listed specialties include Drug Development, Deuterated small molecules, MET kinase inhibitor.

What technology does DeuterOncology NV use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About DeuterOncology NV

DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.

Specialties

Drug DevelopmentDeuterated small moleculesMET kinase inhibitor

Where is DeuterOncology NV located?

DeuterOncology NV lists 1 location.

Liège, Walloon Region, BEHQ
Clos Chanmurly 13

Compare companies similar to DeuterOncology NV

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
DeuterOncology NV
deuteroncology.com
Biotechnology Research22020Liège, Walloon Region
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about DeuterOncology NV

What does DeuterOncology NV do?

DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.

How many employees does DeuterOncology NV have?

DeuterOncology NV has around 2 employees on LinkedIn.

Where is DeuterOncology NV headquartered?

DeuterOncology NV is headquartered in Liège, Walloon Region.

When was DeuterOncology NV founded?

DeuterOncology NV was founded in 2020.

Build a lead list from companies like DeuterOncology NV

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.